Radius Health

Radius Health Debt

Delisted

The Debt of Radius Health (RDUS) as of Oct 27, 2026 is 414.77 M USD. In the previous year, Debt was 249.40 M USD — a change of 66.31% (higher).

Debt

414.77 MUSD

YoY

66.31%

Last updated:

In 2024, Radius Health's total debt was 414.77 M USD, a 66.31% change from the 249.40 M USD total debt recorded in the previous year.

The Radius Health Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
145.10 M USD
Jan 1, 2018
107.40 M USD
Jan 1, 2019
105.10 M USD
Jan 1, 2020
104.40 M USD
Jan 1, 2021
75.00 M USD
Jan 1, 2022
248.60 M USD
Jan 1, 2023
249.40 M USD
Jan 1, 2024
414.77 M USD
The Radius Health Debt history
YEARDebtYoY
414.77 MUSD+66.31%
249.40 MUSD+0.32%
248.60 MUSD+231.47%
75.00 MUSD-28.16%
104.40 MUSD-0.67%
105.10 MUSD-2.14%
107.40 MUSD-25.98%
145.10 MUSD-24.62%
192.50 MUSD-15.64%
228.20 MUSD-28.55%
319.40 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radius Health Stock analysis

What does Radius Health do? Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health is one of the most popular companies on Eulerpool.

Debt Details

Understanding Radius Health's Debt Structure

Radius Health's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Radius Health's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Radius Health’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Radius Health’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Radius Health stock

Debt of Radius Health is 414.77 M USD in 2024.

Debt of Radius Health changed from 249.40 M USD to 414.77 M USD, representing a 66.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Radius Health since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Radius Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Radius Health

All Key Metrics — Radius Health